Page last updated: 2024-10-29

ketamine and Retroperitoneal Neoplasms

ketamine has been researched along with Retroperitoneal Neoplasms in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fazylov, AA1
Shoĭkhetman, IuD1
Dusmuratov, AM1
Abdurasulova, OA1
Umarov, NK1

Other Studies

1 other study available for ketamine and Retroperitoneal Neoplasms

ArticleYear
[A method of echotomography under anesthesia of neoplasms in children].
    Pediatriia, 1988, Issue:1

    Topics: Anesthesia, General; Child, Preschool; Humans; Infant; Infant, Newborn; Ketamine; Kidney Neoplasms;

1988